J. Goldman & CO LP Soleno Therapeutics Inc Transaction History

J. Goldman & CO LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$1.24 - $3.3 $148,642 - $395,580	-119,873 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$1.61 - $2.23 $196,584 - $272,287	-122,102 Reduced 50.46%	119,873 $231,000
Q3 2020 Nov 16, 2020	SELL	$1.71 - $2.51 $265,732 - $390,051	-155,399 Reduced 39.11%	241,975 $607,000
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $453,534 - $1.08 Million	256,234 Added 181.55%	397,374 $882,000
Q1 2020 May 15, 2020	SELL	$1.64 - $3.85 $110,173 - $258,639	-67,179 Reduced 32.25%	141,140 $336,000
Q4 2019 Feb 14, 2020	BUY	$1.35 - $2.95 $281,230 - $614,541	208,319 New	208,319 $612,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $413M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.